MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
September 02, 2021 16:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Sept. 02, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
August 05, 2021 16:30 ET | MacroGenics, Inc.
ROCKVILLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
February 26, 2021 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 26, 2021 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
February 08, 2021 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 08, 2021 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
January 11, 2021 08:45 ET | MacroGenics, Inc.
ROCKVILLE, MD, Jan. 11, 2021 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
November 09, 2020 17:00 ET | MacroGenics, Inc.
ROCKVILLE, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
September 03, 2020 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Sept. 03, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
Mimecast to Present
Mimecast to Present at the Goldman Sachs Technology and Internet Conference 2018
February 06, 2018 16:05 ET | Mimecast Limited
LEXINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Mimecast Limited (NASDAQ:MIME), a leading email and data security company, announced today that Peter Bauer, Mimecast CEO, Chairman and Co-Founder...
Mimecast to Present
Mimecast to Present at the Credit Suisse 21st Annual Technology, Media & Telecom Conference
November 17, 2017 08:00 ET | Mimecast Limited
WATERTOWN, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Mimecast Limited (NASDAQ:MIME), a leading email and data security company, announced today that Peter Campbell, Mimecast Chief Financial Officer,...
Mimecast to Present
Mimecast to Present at the Oppenheimer 20th Annual Technology, Internet & Communications Conference
August 03, 2017 08:00 ET | Mimecast Limited
WATERTOWN, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Mimecast Limited (NASDAQ:MIME), a leading email and data security company, announced today that Peter Bauer, Mimecast CEO and Co-founder, and...